Cargando…

TREATMENT BY IMIPRAMINE OF DEAFNESS AND DEPRESSION

Detalles Bibliográficos
Autor principal:	Srivastava, V.K.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 1998
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965848/ https://www.ncbi.nlm.nih.gov/pubmed/21494472

Ejemplares similares

Acute Abdomen Following Abrupt Cessation of Imipramine - A Case Report
por: Gupta, Rajeev, et al.
Publicado: (1985)

MULTICENTRIC EFFICACY STUDY OF CENTPROPAZINE AND IMIPRAMINE IN DEPRESSED PATIENTS
por: Srivastava, J.S., et al.
Publicado: (1999)

IMIPRAMINE IN SCHIZOPHRENIA WITH DEPRESSIVE SYMPTOMATOLOGY1
por: Dua, Dinesh, et al.
Publicado: (1990)

Acute Abdomen in a Child following Abrupt Withdrawal of Imipramine - A Case Report
por: Gupta, Rajeev
Publicado: (1989)

A DOUBLE-BLIND EVALUATION OF ALPRAZOLAM AND IMIPRAMINE IN THE TREATMENT OF MAJOR DEPRESSION
por: Murthy, R.S., et al.
Publicado: (1991)

Accelerated antidepressant response to lithium augmentation of imipramine
por: Saini, Rajiv, et al.
Publicado: (2016)

Radium in the Treatment of Deafness
por: Willson, Howard S.
Publicado: (1914)

Radium in the Treatment of Deafness
por: McColloch, H. D.
Publicado: (1914)

A COMPARATIVE STUDY OF DOTHIEPIN (PROTHIADEN) AND IMIPRAMINE IN DEPRESSION
por: Vyas, J.N., et al.
Publicado: (1989)

EFFECT OF IMIPRAMINE AND ECT ON PLATELET MAO ACTIVITY IN DEPRESSIVES
por: Trivedi, J.K., et al.
Publicado: (1989)

Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients
por: Avasthi, Ajit, et al.
Publicado: (2005)

Resilience and Handicap in Deaf
por: FARAHANI, Farhad, et al.
Publicado: (2015)

Anesthesia for the deaf and mute
por: Bhalotra, Anju Romina, et al.
Publicado: (2017)

The effect of imipramine, ketamine, and zinc in the mouse model of depression
por: Wróbel, Andrzej, et al.
Publicado: (2015)

CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)

NOREPINEPHRINE AND SEROTONIN METABOLISM AND CLINICAL RESPONSE TO COMBINED IMIPRAMINE AND AMITRIPTYLINE THERAPY IN DEPRESSION
por: Palaniappun, V., et al.
Publicado: (1991)

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
por: Le Noury, Joanna, et al.
Publicado: (2015)

Do Age-related Differences in the Incidence of Mumps Deafness Reflect a True Difference or a Misclassification of Mumps Deafness?
por: Fujiwara, Takashi, et al.
Publicado: (2022)

Acute Onset of Tinnitus and Sudden Deafness: Correspondence
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Possible mechanisms for sensorineural hearing loss and deafness in patients with propionic acidemia
por: Grünert, S. C., et al.
Publicado: (2017)

Response to Letter to the Editor: Do Age-related Differences in the Incidence of Mumps Deafness Reflect a True Difference or a Misclassification of Mumps Deafness?
por: Takagi, Akira, et al.
Publicado: (2022)

What Should the Deaf Do?
por: Jones, Morris
Publicado: (1889)

A COMPARATIVE EVALUATION OF DOTHIEPIN (PROTHIEDEN) AND IMIPRAMINE
por: Chaturvedi, M. K., et al.
Publicado: (1980)

Granulomatous drug eruption associated with imipramine
por: Pascucci, Anabella
Publicado: (2018)

Cortical Deafness and Tinnitus Following Sequential Bilateral Putaminal Hemorrhage
por: Yang, Shilin, et al.
Publicado: (2020)

POST DEXAMETHASONE PLASMA CORTISOL LEVELS IN DEPRESSIVES TREATED WITH IMIPRAMINE AND ELECTROCONVULSIVE THERAPY5
por: Varma, S.L., et al.
Publicado: (1989)

Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
por: Le Noury, Joanna, et al.
Publicado: (2016)

Type 2 First Branchial Cleft Cyst Presenting as Childhood Deafness
por: Bylappa, SunilKumar, et al.
Publicado: (2011)

Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression
por: Shahsavand Ananloo, Esmaeil, et al.
Publicado: (2013)

The next psychoactive drugs: From imipramine to ketamine
por: Carrillo, Pablo, et al.
Publicado: (2020)

Safety and efficacy of ketamine infusion in late onset depression, and conversion to treatment response
por: Srivastava, Shrikant, et al.
Publicado: (2015)

Treatment of imipramine-induced hyperpigmentation with quality-switched ruby and picosecond lasers
por: Hamid, Ramiz Nayyer, et al.
Publicado: (2021)

STRESS, DEPRESSION AND GENOMIC CHANGE
por: Srivastava, J.S., et al.
Publicado: (1998)

New approach for promoting HPV vaccination in college men based on multi-theory model (MTM) of health behavior change
por: Sharma, M., et al.
Publicado: (2017)

Simultaneous Spectrophotometric Estimation of Imipramine Hydrochloride and Chlordiazepoxide in Tablets
por: Patel, Sejal, et al.
Publicado: (2009)

RP-HPLC Estimation of Imipramine Hydrochloride and Diazepam in Tablets
por: Srikantha, D., et al.
Publicado: (2015)

Imipramine blocks acute silicosis in a mouse model
por: Biswas, Rupa, et al.
Publicado: (2017)

Will EGFRvIII and neuronal-derived EGFR be targets for imipramine?
por: Li, Zesheng, et al.
Publicado: (2023)

Effects of Tibetan medicine metacinnabar (β-HgS) combined with imipramine or sertraline on depression-like symptoms in mice
por: Qiao, Yajun, et al.
Publicado: (2022)

Pontobulbar palsy and sensorineural deafness (Brown-Vialetto-van Laere syndrome): A case from Northwest Iran
por: Toopchizadeh, Vahideh, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_678hf7okq548fr9un0l53eg5al